Registry for women with breast implant-associated lymphoma
Official title: Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry
Run by The Lymphoma Academic Research Organisation · NCT04220970 · Data updated 2026-11-12
This study is collecting information from women with a rare type of lymphoma linked to breast implants to help doctors understand and manage the condition better.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 150 (estimated) |
| Sponsor | The Lymphoma Academic Research Organisation Academic / other |
| Locations | 31 sites (Bruges and 30 other locations) |
| Status | Recruiting |
| Started | June 7, 2017 |
| Main results expected | June 7, 2032 |
| Study ends | June 7, 2032 |
| Registry record updated | January 14, 2026 |
| Trial ID | NCT04220970 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry are adult women diagnosed with anaplastic large cell lymphoma associated with breast implants.
✕Probably not a fit
Patients without breast implants or those not diagnosed with BIA-ALCL will not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This registry aims to collect data on women diagnosed with anaplastic large cell lymphoma associated with breast implants (BIA-ALCL). It is established in France and Belgium to better understand this rare condition and facilitate multidisciplinary discussions regarding patient care. The registry will gather clinical information to improve awareness and management of BIA-ALCL among healthcare professionals. By documenting cases, the registry seeks to enhance knowledge about the disease's incidence and outcomes.
Why it matters
Potential benefit: If successful, this registry could lead to improved diagnosis, treatment, and management strategies for patients with BIA-ALCL.
How similar studies have gone: While this registry approach is novel for BIA-ALCL, similar registries for rare diseases have shown success in improving patient outcomes and understanding of the conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients with an anaplastic large cell lymphoma associated with breast implants Exclusion Criteria: \-
Where it's running
-
A. Z. Sint-Jan Brugge-Oostende AV
Bruges, Belgium Recruiting -
Clinique Universitaire Saint LUC
Brussels, Belgium Recruiting -
Institut Jules Bordet
Brussels, Belgium Recruiting -
Universitair Ziekenhuis Gent
Ghent, Belgium Recruiting -
U.Z. Leuven - Campus Gasthuisberg
Leuven, Belgium Recruiting -
CHU de Liège -Domaine Sart Tilman
Liège, Belgium Recruiting
Show 25 more locations
-
CHU UCL Namur - Site Godinne
Yvoir, Belgium Recruiting -
CH d Avignon - Hopital Henri Duffaut
Avignon, France Recruiting -
Institut Bergonié
Bordeaux, France Recruiting -
CHRU de Brest - Hôpital Morvan
Brest, France Recruiting -
Hopital Louis Pasteur
Colmar, France Recruiting -
APHP - Hopital Henri Mondor
Créteil, France Recruiting -
CHU de Dijon - Hôpital le Bocage
Dijon, France Recruiting -
Centre Médical la Roseraie
Lille, France Recruiting -
Centre Léon Bérard
Lyon, France Recruiting -
Institut Paoli Calmettes
Marseille, France Recruiting -
CH Saint-Eloi
Montpellier, France Recruiting -
CHU de Nantes - Hôtel Dieu
Nantes, France Recruiting -
Hôpital Cochin
Paris, France Recruiting -
CH de Pau
Pau, France Recruiting -
CH de Perpigan
Perpignan, France Recruiting -
Centre Hospitalier Lyon Sud
Pierre-Bénite, France Recruiting -
Chu de Reims - Hopital Robert Debre
Reims, France Recruiting -
Centre Henri Becquerel
Rouen, France Recruiting -
Centre Rene Hugenin
Saint-Cloud, France Recruiting -
CH de Saint Malo
St-Malo, France Recruiting -
CHRU de Strasbourg
Strasbourg, France Recruiting -
Institut Universitaire du Cancer - Oncopole Toulouse (IUCT-O)
Toulouse, France Recruiting -
Cliniques Universitaires de Bruxelles - Hôpital Erasme
Brussels, Belgium Not yet recruiting -
Universitair Ziekenhuis Brussel
Brussels, Belgium Not yet recruiting -
Universitair Ziekenhuis Antwerpen
Edegem, Belgium Not yet recruiting
Study contacts
- Study coordinator: Manon Croix
- Email: manon.croix.ext@lysarc.org
- Phone: +33 (04) 72 66 93 33
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.